DGX - QUEST DIAGNOSTICS INC

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 189.51

Open

$ 187.61

Bid

$ 184.39 x 41

Ask

$ 190.56 x 3

Day's Range

$ 187.05 - $ 190.08

52 Week Range

$ 144.18 - $ 190.64

Volume

983,924

Average Volume

Market Cap

21.19B

Beta (5Y Monthly)

$ 0.40

PE Ratio (TTM)

$ 22.31

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.02)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-23-2025	06-30-2025	10-Q
2	04-23-2025	03-31-2025	10-Q
3	02-20-2025	12-31-2024	10-K
4	10-23-2024	09-30-2024	10-Q
5	07-24-2024	06-30-2024	10-Q
6	04-24-2024	03-31-2024	10-Q
7	02-22-2024	12-31-2023	10-K
8	10-25-2023	09-30-2023	10-Q
9	07-27-2023	06-30-2023	10-Q
10	04-28-2023	03-31-2023	10-Q
11	02-21-2023	12-31-2022	10-K
12	10-21-2022	09-30-2022	10-Q
13	07-22-2022	06-30-2022	10-Q
14	04-22-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	10-22-2021	09-30-2021	10-Q
17	07-23-2021	06-30-2021	10-Q
18	04-23-2021	03-31-2021	10-Q
19	02-22-2021	12-31-2020	10-K
20	10-23-2020	09-30-2020	10-Q
21	07-24-2020	06-30-2020	10-Q
22	05-04-2020	03-31-2020	10-Q
23	02-20-2020	12-31-2019	10-K
24	10-23-2019	09-30-2019	10-Q
25	07-24-2019	06-30-2019	10-Q
26	04-24-2019	03-31-2019	10-Q
27	02-21-2019	12-31-2018	10-K
28	10-24-2018	09-30-2018	10-Q
29	07-25-2018	06-30-2018	10-Q
30	04-20-2018	03-31-2018	10-Q
31	02-23-2018	12-31-2017	10-K
32	10-19-2017	09-30-2017	10-Q
33	07-25-2017	06-30-2017	10-Q
34	04-21-2017	03-31-2017	10-Q
35	02-22-2017	12-31-2016	10-K
36	10-21-2016	09-30-2016	10-Q
37	07-25-2016	06-30-2016	10-Q
38	04-27-2016	03-31-2016	10-Q
39	02-26-2016	12-31-2015	10-K
40	10-29-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UBS Maintains Neutral on Quest Diagnostics...
10/17/2025 13:52:25

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $180 to $190.

Mizuho Maintains Outperform on Quest Diagn...
10/17/2025 13:26:40

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the price target from $190 to $...

7 Analysts Have This To Say About Quest Di...
10/08/2025 18:00:59

Evercore ISI Group Maintains In-Line on Qu...
10/08/2025 13:09:46

Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Line and raises the price tar...

Guardant Health And Quest Diagnostics Coll...
09/24/2025 12:19:19

Collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest&...

Quest Diagnostics Expands Epic Integration...
09/23/2025 11:10:26

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the custome...

Quest Diagnostics Announces Advanced Pharm...
09/04/2025 13:36:57

New Service Empowers Clinicians with Personalized Insights from Coriell Life Sciences to Optimize Prescribing Across Specialtie...

Corewell Health And Quest Diagnostics Form...
08/26/2025 13:13:05

Parties to build state-of-the-art laboratory in Southfield to serve physicians and patients across the stateQuest will also man...

this-quest-diagnostics-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday

This Quest Diagnostics Analyst Is No Longe...
08/25/2025 18:09:42

A Glimpse Into The Expert Outlook On Quest...
08/25/2025 18:01:34

Baird Downgrades Quest Diagnostics to Neut...
08/25/2025 14:22:06

Baird analyst Eric Coldwell downgrades Quest Diagnostics (NYSE:DGX) from Outperform to Neutral and maintains the price targe...

Quest Diagnostics' Haystack MRD Test Grant...
08/25/2025 12:52:44

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Dr...

What Does the Market Think About Quest Dia...
08/13/2025 13:00:34

Quest Diagnostics' Athena Diagnostics Anno...
07/29/2025 12:58:37

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of diseaseBOSTON, Jul...

Athena Diagnostics Launches New Genetic Te...
07/29/2025 12:56:32

New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of diseaseBOSTON, Jul...

options-corner-quest-diagnostics-post-earnings-digestion-drama-opens-a-science-backed-opportunity

Options Corner: Quest Diagnostics' Post-Ea...
07/24/2025 20:09:05

Quest Diagnostics delivered better-than-expected Q2 earnings results, yet DGX stock stumbled, which opens a contrarian opportun...

UBS Maintains Neutral on Quest Diagnostics...
07/23/2025 19:07:52

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $175 to $180.

Truist Securities Maintains Hold on Quest ...
07/23/2025 14:57:22

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target fro...

Deutsche Bank Maintains Hold on Quest Diag...
07/23/2025 14:25:47

Deutsche Bank analyst Pito Chickering maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target from $1...

Looking Into Quest Diagnostics's Recent Sh...
07/22/2025 19:00:26